Loading provider…
- Featuresarrow_drop_down
- Solutionsarrow_drop_down
Loading provider…
Your Medical Sales Assistants that help you easily find, convert and close your ideal providersMedical Oncology Physician in Wyoming, MI
NPI: 1417153701Primary Practice Location
UNIVERSITY OF MICHIGAN HEALTH - WEST
5900 Byron Center Ave Sw, Wyoming, MI
Primary Employer
Metropolitan Hospital
uofmhealthwest.org
HQ Phone
Get M.D. Ben's Phone Numberphone_androidMobile
Get M.D. Ben's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardFL State Medical License
MI State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 177 | 346 |
| 2 | 99213Established patient office or other outpatient visit, typically 15 minutes | 85 | 102 |
| 3 | 99215Established patient office or other outpatient, visit typically 40 minutes | 69 | 160 |
| 4 | 99223Initial hospital inpatient care, typically 70 minutes per day | 51 | 55 |
| 5 | 99233Subsequent hospital inpatient care, typically 35 minutes per day | 46 | 110 |
Lead Sponsor: Veru Inc.
Intervention / Treatment: DRUG: Exemestane, DRUG: Enobosarm
Lead Sponsor: Alliance for Clinical Trials in Oncology
Collaborators: National Cancer Institute (NCI)
Intervention / Treatment: DRUG: Carboplatin, OTHER: Questionnaire Administration, OTHER: Quality-of-Life Assessment, DRUG: Pembrolizumab, DRUG: Pemetrexed, OTHER: Comprehensive Geriatric Assessment
Lead Sponsor: Alliance Foundation Trials, LLC.
Collaborators: Pfizer, Syneos Health, GBG Forschungs GmbH, UNICANCER, Fondazione Michelangelo, PrECOG, LLC., Breast Cancer Trials, Australia and New Zealand, SOLTI Breast Cancer Research Group
Intervention / Treatment: DRUG: Exemestane, DRUG: Fulvestrant, DRUG: Anastrozole, DRUG: letrozole, DRUG: trastuzumab, DRUG: palbociclib, DRUG: pertuzumab
